July 8, 2024 6:59 PM

Study identifies thousands of high-risk cancer gene variants

Scientists have made a groundbreaking discovery, identifying over 5,000 genetic variations that contribute to cancer growth. This landmark study, conducted by researchers from the Wellcome Sanger Institute, The Institute of Cancer Research, London, and the University of Cambridge, also uncovered a potential therapeutic target for treating and possibly preventing certain cancers. The research, published in Nature Genetics, focused on the BAP1 gene, known as a 'tumor defense' gene. Using an innov...